You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

EN RO
MINISTRY OF EDUCATION AND RESEARCH
MINISTRY OF HEALTH
NATIONAL AGENCY FOR RESEARCH AND DEVELOPMENT
THE REGIONAL INSTITUTE OF ONCOLOGY IASI
TRANSCEND RESEARCH CENTRE
dreapta1
dreapta2
dreapta3
dreapta4

logo-ntl
PNCDI IV Program – Bilateral Cooperation
Understanding the Process and Formulation Variables in the Design of pH-Sensitive Liposomes for Anticancer Drug Delivery

Program: PN IV – PCB-RO-MD-2024


Nr: 61PCBROMD/01.10.2025

Abstract


Engineering nanocarriers for antitumor pharmaceuticals focuses on targeting and accumulating in the tumor. Then, the release of their cargo under local stimuli, e.g. pH, temperature, and ionic strength occurs. pH is a critical stimulus as it varies between normal and tumor cells, as well as inside and outside cells, creating a gradient exploitable for developing effective nanocarriers for cancer treatment. The OncoSensLip project aims to develop optimized pH-sensitive liposomal formulations to enhance anticancer drug delivery. pH-responsive nanocarriers include liposomes with known biocompatibility and the ability to encapsulate hydrophilic and hydrophobic drugs. This project seeks to advance current liposomal designs by systematically exploring the impact of formulation and process variables (e.g., lipid type) and preparation method (e.g., thin-film hydration, microfluidics) on key physico-chemical properties of liposomes. OncoSensLip will evaluate optimized liposomal formulations for controlled drug release under various biological-like experimental conditions with focus on pH. Then, in vitro studies in glioblastoma and breast cancer models will assess the therapeutic efficiency and cytotoxicity of these liposomal systems. The outcomes will contribute to translational nanomedicine, offering optimized protocols for pH-sensitive liposome production and enhancing technical capabilities through training and collaborative research between Romanian and Moldovan institutions.

General information


Financial State budget
PN IV Program European and International Cooperation
Project type Bilateral/Multilateral Sub-program
Project value 750.000,00 lei (600.000,00 UEFISCDI + 150.000,00 ANCD)
Project period 24 months (01.10.2025 – 30.09.2027)
Project authority Executive Unit for Financing Higher Education and University Scientific Research (UEFISCDI), Romania & National Agency for Research and Development (ANCD), Republic of Moldova
Coordinator The Regional Institute of Oncology Iasi
Partner State University of Medicine and Pharmacy Nicolae Testemitanu
Project director CSII Dr. Brindusa Dragoi
Project co-director Assoc. Prof. Dr. Cristina Ciobanu

Objective


The overall aim of the OncoSensLip project is to develop a pH-sensitive liposomal formulations for anticancer drug delivery by adjusting formulation and process variables, while building capacity among project partners.
Specific objectives (SO):
SO1. Formulation and Process Optimization
SO2. Drug Release and In Vitro Performance
SO3. Training and Capacity Building

Financial resources


Budget category 2025
(lei)
2026
(lei)
2027
(lei)
TOTAL BUDGET
(lei)
Coordinator Partner Coordinator Partner Coordinator Partner Coordinator Partner
Staff costs 15,000.00   60,000.00   37,500.00   112,500.00  
Logistics 50,000.00   45,000.00   36,250.00   131,250.00  
Travel 0.00 0.00 9,375.00 117,000.00 9,375.00 108,000.00 18,750.00 225,000.00
Indirect cost
(max. 30% of the coordinator’s budget)
27,857.00   49,018.00   35,625.00   112,500.00  
TOTAL 92,857.00 0.00 163,393.00 117,000.00 118,750.00 108,000.00 375,000.00 225,000.00
92,857.00 280,393.00 226,750.00 600,000.00

Work plan


An Work plan
2025
(3 months)
  • Lipid selection, literature review, and preliminary tests
  • Kick-off meeting
  • Risk management plan
  • Communication, dissemination, promotion and exploitation plan
  • Project planning
2026
(12 months)
  • Design and preparation of liposomes by thin film hydration and microfluidics
  • Physico-chemical characterization of liposomal formulations
  • Biological effects of liposomal formulations on cell lines
  • Mobility and training
  • Networking and collaboration
  • Communication, dissemination and promotion
2027
(9 months)
  • Stability studies of liposomal formulations
  • In vitro control release studies
  • Cytotoxicity studies
  • Mobility and training
  • Communication, dissemination and promotion

Communication, dissemination, and impact


Cognitive and Socio-Economic Impact of the Project

Cognitive Impact
The project contributes to the advancement of scientific knowledge in the field of oncology by strengthening collaboration between the two partner institutions in Romania and the Republic of Moldova. The research activities carried out within this partnership will facilitate the exchange of knowledge, methods, and best practices among the specialists involved, supporting the development of innovative approaches in the treatment of oncological diseases through the design and preparation of pH-sensitive liposomal formulations.

Through the implementation of the project, new scientific results will be generated and disseminated via publications, conference presentations, and academic cooperation activities. Moreover, the project supports the professional development of the researchers involved and enhances the research capacity of the participating institutions.

Socio-Economic Impact
The project has the potential to generate significant societal benefits by improving collaboration between Romania and the Republic of Moldova in the healthcare sector and by facilitating the transfer of knowledge and technologies between the two countries. The results obtained may contribute to the development of more effective solutions for the treatment of oncological diseases, with a direct impact on the quality of medical services and patient care.

In the long term, the project may support the development of research and innovation infrastructure in the biomedical field, fostering collaboration among academia, medical institutions, and other relevant organizations. Strengthening scientific cooperation between the two countries will also increase the international visibility of research outcomes and contribute to the socio-economic development of the region.

  • A. Publications
  • B. Communication, dissemination, promotion
    • Cristina Ciobanu, Brindusa Dragoi, “OncoSensLip” - Optimization of Process and Formulation Variables in the Design of pH-Sensitive Liposomes for Anticancer Drug Delivery, MedMolMed 2025, November 10-15, 2025, Chisinau, Republic of Moldova
    • OncoSensLip project flyer distributed to the Workshop “Nanomedicina în terapia și diagnosticul cancerului”, organized by the ESEI-BioMed Project at IRO Iasi, November 26, 2025; workshop for non-scientific community
  • C. Main achievements
  • A. Publications
  • B. Communication, dissemination, promotion
  • C. Main achievements
  • A. Publications
  • B. Communication, dissemination, promotion
  • C. Main achievements

Research Team


CSII Dr. Brindusa Dragoi – project director
Conf. Dr. Cristian Ciobanu – project co-director
Conf Dr. Maria-Daniela Vlad – experienced researcher
Dr. Camelia-Mihaela Zara Danceanu – postdoctoral researcher
Dr. Razvan Ghiarasim – postdoctoral researcher
Dr. Liliana Andronache – postdoctoral researcher
Dr. Dan Lisii, MD – postdoctoral researcher
Nicoleta Basoc – PhD student
Ecaterina Mazure – PhD student
Sergiu Coseri – PhD student

Contact


CSII Dr. Brindusa Dragoi

Regional Institute of Oncology Iasi
TRANSCEND Research Centre
Nanotechnology Laboratory
Str. General Henri Mathias Berthelot 2-4,
Iași 700483

E-mail: brindusa.dragoi@yahoo.com / transcendbd@iroiasi.ro

Conf Dr. Cristina Ciobanu

"Nicolae Testemitanu" State University of Medicine and Pharmacy of the Republic of Moldova
Faculty of Pharmacy
Department of Pharmaceutical Technology

E-mail: cristina.ciobanu@usmf.md

Acest site folosește cookie-uri
Folosim cookie-uri pentru a personaliza conținutul, pentru a oferi funcții de rețele sociale și pentru a analiza traficul. De asemenea, le oferim partenerilor de rețele sociale, de publicitate și de analize informații cu privire la modul în care folosesc site-ul nostru. Aceștia le pot combina cu alte informații oferite de dvs. sau culese în urma folosirii serviciilor lor. Prin continuarea navigării, ești de acord cu Politica de Cookies.